When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?

BACKGROUND: Limited data exist to describe end‐of‐treatment (EOT) parameters of antifungal therapy for invasive mould infections (IMI). METHODS: In a 10‐year cohort of consecutive adult allogeneic haematopoietic cell transplant recipients with proven/probable IMI, we describe treatment duration and...

Descripción completa

Detalles Bibliográficos
Autores principales: Roth, Romain Samuel, Masouridi‐Levrat, Stavroula, Giannotti, Federica, Mamez, Anne‐Claire, Morin, Sarah, van Delden, Christian, Chalandon, Yves, Neofytos, Dionysios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796773/
https://www.ncbi.nlm.nih.gov/pubmed/35815918
http://dx.doi.org/10.1111/myc.13496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796773/
https://www.ncbi.nlm.nih.gov/pubmed/35815918
http://dx.doi.org/10.1111/myc.13496

Ejemplares similares